Aldi, Hy-Vee Recall Cream Cheese Products Over Potential Salmonella Contamination 
Dolly Parton Serves Up Sweetness with Krispy Kreme Collaboration 
ALWAYTH x Adidas Samba: Revolutionizing Sneaker Culture with Fashion-Forward Collaboration 
Converse Faces Job Cuts as Nike Aims for $2 Billion in Cost Savings 
How supermarkets are changing their branding to make you think they’re cheaper 
Green industry yes, conservation no: a budget for people, not for nature 
The 2023 Sir Paul Curran award for academic journalism goes to Barbara Sahakian 
PUMA Welcomes AC Milan Star Theo Hernández to the Family 
McDonald’s Rolls Out $5 Meal Deals to Emphasize Affordability Amid Rising Costs 
Coca-Cola Launches Data-Driven Insights Platform for Retail and Foodservice Industries 
Skepta and PUMA Launch Groundbreaking Collection 
Burger King Introduces Mozzarella Fries: A New Spin on an Old Favorite 
McDonald's Faces Backlash Over $5 Meal Deal: Customers Call It 'Skimpy' 
Coca-Cola Launches Lens Platform to Offer Key Data for Retail and Foodservice 
MENLO PARK, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the following investor conferences:
- Piper Jaffray 27th Annual Healthcare Conference in New York at 8:30 a.m. ET on Wednesday, December 2, 2015. The live and archived webcast will be available at http://edge.media-server.com/m/p/u46tsbd2.
- Oppenheimer 26th Annual Healthcare Conference in New York at 9:45 a.m. ET on December 9, 2015. The live and archived webcast will be available at http://www.veracast.com/webcasts/opco/healthcare2015/84203554236.cfm.
Geron management will also be hosting an analyst and investor meeting to discuss imetelstat data presented at the 57th American Society of Hematology (ASH) Annual Meeting:
- The meeting will be held at 7:30 p.m. ET on Saturday, December 5, 2015. The live and archived webcast will be available at http://edge.media-server.com/m/p/o3ovz2db/lan/en.
Following the live presentations, the webcasts will be archived and available for replay for a period of 30 days.
About Geron
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT: Anna Krassowska, Ph.D. Investor and Media Relations 650-473-7765 [email protected] [email protected]
